Skip to main content
. Author manuscript; available in PMC: 2018 Jan 18.
Published in final edited form as: Am J Transplant. 2018 Jan;18(Suppl 1):18–113. doi: 10.1111/ajt.14557

Figure KI 125. Incidence of PTLD among pediatric kidney transplant recipients by recipient EBV status at transplant, 2004–2014.

Figure KI 125

Cumulative incidence is estimated using the Kaplan-Meier competing risk method. Posttransplant lymphoproliferative disorder (PTLD) is identified as a reported complication or cause of death on the OPTN Transplant Recipient Follow-up Form or on the Posttransplant Malignancy Form as polymorphic PTLD, monomorphic PTLD, or Hodgkin disease. Only the earliest date of PTLD diagnosis is considered. EBV, Epstein-Barr virus.